Zymeworks Inc. (NYSE:ZYME) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation […]
